You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 5,891,843


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,891,843
Title: Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use
Abstract:The invention relates to a pharmaceutical composition for the treatment of patients with blood coagulation diseases which are caused by coagulation factor deficiency and/or inhibitors of coagulation factors, whereby the composition has a FEIB-activity and is characterized in that it has Factor VIIa and at least one further active ingredient and the activity of at least 10 Factor VIIa units per unit FEIBA. Additionally, the invention comprises a method for the production of the pharmaceutical preparation and its use.
Inventor(s): Turecek; Peter (Klosterneuburg, AT), Schwarz; Hans-Peter (Vienna, AT), Redl; Gerda (Rutendorf, AT)
Assignee: Immuno Aktiengesllschaft (Vienna, AT)
Application Number:08/701,755
Patent Claims:1. A pharmaceutical composition with FEIB-activity for treating a patient with a blood coagulation disorder selected from the group consisting of blood coagulation deficienxcy and blood coagulation inhibition, comprising Factor VIIa and at least one additional active ingredient, wherein the composition has an activity of at least 10 Factor VIIa units per unit FEIB-activity, and FEIB-activity of more than 5 U/ml.

2. The pharmaceutical composition according to claim 1, wherein the composition has an activity of 10 to 100 Factor VIIa units per unit FEIB-activity.

3. The pharmaceutical composition according to claim 2, wherein the composition has an activity of 10 to 20 Factor VIIa units per unit FEIB-activity.

4. The pharmaceutical composition according to claim 3, wherein the composition has an activity of 10 to 15 Factor VIIa units per unit FEIB-activity.

5. The pharmaceutical composition according to claim 1, wherein the additional active ingredient is selected from the group consisting of Factor II, Factor IX, Factor IXa, Factor X and Factor Xa.

6. The pharmaceutical composition according to claim 5, wherein the additional active ingredient is present in a range of 0.5 to 2 activity units per unit FEIB-activity.

7. The pharmaceutical composition according to claim 6, wherein the additional active ingredient is present in a range of 0.5 to 1.5 activity units per unit FEIB-activity.

8. The pharmaceutical composition according to claim 1, further comprising at least one protein selected from the group consisting of protein C and protein S.

9. A pharmaceutical composition according to claim 1, wherein the composition includes a purified prothrombin complex and the specific activity of Factor VIIa greater than 10 U/mg total protein.

10. A pharmaceutical composition according to claims 1, wherein the composition includes a purified partial prothrombin complex and the specific activity of Factor VIIa greater than 10 U/mg total protein.

11. A pharmaceutical composition according to claim 9, wherein the prothrombin complex is an activated prothrombin complex or a FEIBA preparation.

12. A pharmaceutical composition according to claim 10, wherein the purified partial prothrombin complex is an activated prothrombin complex or a FEIBA preparation.

13. A pharmaceutical composition according to claims 5, wherein the Factor VIIa and additional ingredient are obtained from the same plasma pool.

Details for Patent 5,891,843

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Baxalta Us Inc. AUTOPLEX, FEIBA NF, FEIBA VH anti-inhibitor coagulant complex For Injection 101447 12/21/1979 ⤷  Try a Trial 2015-08-28
Baxalta Us Inc. AUTOPLEX, FEIBA NF, FEIBA VH anti-inhibitor coagulant complex For Injection 101447 07/31/2000 ⤷  Try a Trial 2015-08-28
Baxalta Us Inc. AUTOPLEX, FEIBA NF, FEIBA VH anti-inhibitor coagulant complex For Injection 101447 08/11/2005 ⤷  Try a Trial 2015-08-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.